U.S. markets closed
  • S&P 500

    +39.95 (+1.06%)
  • Dow 30

    +321.86 (+1.05%)
  • Nasdaq

    +99.14 (+0.90%)
  • Russell 2000

    +19.77 (+1.16%)
  • Crude Oil

    -0.25 (-0.23%)
  • Gold

    +8.20 (+0.46%)
  • Silver

    +0.14 (+0.70%)

    +0.0017 (+0.17%)
  • 10-Yr Bond

    -0.0830 (-2.79%)

    +0.0006 (+0.05%)

    -0.2170 (-0.16%)

    -8.56 (-0.04%)
  • CMC Crypto 200

    -3.01 (-0.72%)
  • FTSE 100

    -0.63 (-0.01%)
  • Nikkei 225

    0.00 (0.00%)

A $138.8 Billion Global Opportunity for Nanotechnology in Drug Delivery by 2026 - New Research from StrategyR

·4 min read

SAN FRANCISCO, Sept. 3, 2021 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Nanotechnology in Drug Delivery - Global Market Trajectory & Analytics". The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.

Nanotechnology in Drug Delivery
Nanotechnology in Drug Delivery

Edition: 15; Released: April 2021
Executive Pool: 3413
Companies: 36 - Players covered include AbbVie Inc.; Aquanova AG; BlueWillow Biologics; Camurus AB; Celgene, Inc.; Ceramisphere Health Pty Limited; Cristal Therapeutics; CYTIMMUNE SCIENCES, Inc.; EnColl Corporation; EyePoint Pharmaceuticals; Lena Nanoceutics Ltd.; Nanobiotix; NanoCarrier Co., Ltd.; NanOlogy LLC; Nanospectra Biosciences, Inc.; Parvus Therapeutics Inc.; Selecta Biosciences; Starpharma Holdings Limited; Taiwan Liposome Co., ; Tarveda Therapeutics and Others.
Coverage: All major geographies and key segments
Segments: Technology (Nanocrystals, Nanocarriers)
Geographies: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Complimentary Project Preview - This is an ongoing global program. Preview our research program before you make a purchase decision. We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies. Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more. You may also build your own bespoke report using our MarketGlass™ Platform which offers thousands of data bytes without an obligation to purchase our report. Preview Registry


Global Nanotechnology in Drug Delivery Market to Reach $138.8 Billion by 2026
Amid the COVID-19 crisis, the global market for Nanotechnology in Drug Delivery estimated at US$47.5 Billion in the year 2020, is projected to reach a revised size of US$138.8 Billion by 2026, growing at a CAGR of 19.4% over the analysis period. Nanocrystals, one of the segments analyzed in the report, is projected to record a 17.3% CAGR and reach US$83.1 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Nanocarriers segment is readjusted to a revised 21.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $15.2 Billion in 2021, While China is Forecast to Reach $31.4 Billion by 2026
The Nanotechnology in Drug Delivery market in the U.S. is estimated at US$15.2 Billion in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$31.4 Billion by the year 2026 trailing a CAGR of 24.5% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.2% and 17% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 15.2% CAGR. More

MarketGlass™ Platform
Our MarketGlass™ Platform is a free full-stack knowledge center that is custom configurable to today`s busy business executive`s intelligence needs! This influencer driven interactive research platform is at the core of our primary research engagements and draws from unique perspectives of participating executives worldwide. Features include - enterprise-wide peer-to-peer collaborations; research program previews relevant to your company; 3.4 million domain expert profiles; competitive company profiles; interactive research modules; bespoke report generation; monitor market trends; competitive brands; create & publish blogs & podcasts using our primary and secondary content; track domain events worldwide; and much more. Client companies will have complete insider access to the project data stacks. Currently in use by 67,000+ domain experts worldwide.

Our platform is free for qualified executives and is accessible from our website www.StrategyR.com or via our just released mobile application on iOS or Android

About Global Industry Analysts, Inc. & StrategyR™
Global Industry Analysts, Inc., (www.strategyr.com) is a renowned market research publisher the world`s only influencer driven market research company. Proudly serving more than 42,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for over 33 years.

Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
Email: ZA@StrategyR.com

Join Our Expert Panel

Connect With Us on LinkedIn

Follow Us on Twitter

Journalists & Media


View original content to download multimedia:https://www.prnewswire.com/news-releases/a-138-8-billion-global-opportunity-for-nanotechnology-in-drug-delivery-by-2026---new-research-from-strategyr-301368305.html

SOURCE Global Industry Analysts, Inc.